SCHEMBL5925544

SCHEMBL5925544

CCCOc1cc(N)ccc1C(=O)OCC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.72
CYP2D6 P10635 2/20 0.72
SCN1A P35498 2/20 0.72
SCN2A Q99250 2/20 0.72
SCN3A Q9NY46 2/20 0.72
ALDH1A1 P00352 6/20 0.50
GAA P10253 4/20 0.50
MAPT P10636 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
KDM4E B2RXH2 1/20 0.50
USP2 O75604 1/20 0.50
TP53 P04637 1/20 0.50
POLB P06746 1/20 0.50
CASP1 P29466 1/20 0.50
HTT P42858 1/20 0.50
CASP7 P55210 1/20 0.50
ATM Q13315 1/20 0.50
LMNA P02545 5/20 0.49
MAOA P21397 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22987103 0.93 CYP1A2 (0.78) CYP1A2CYP2D6SCN1ASCN2ASCN3A
SCHEMBL4001016 0.89 CYP1A2 (0.58) CYP1A2CYP2D6SCN1ASCN2ASCN3A
SCHEMBL10246464 0.87 CYP1A2 (0.70) CYP1A2CYP2D6SCN1ASCN2ASCN3A
SCHEMBL31107344 0.85 CYP1A2 (0.55) CYP1A2CYP2D6SCN1ASCN2ASCN3A
SCHEMBL14304166 0.85 CYP1A2 (0.80) CYP1A2CYP2D6SCN1ASCN2ASCN3A
SCHEMBL14974921 0.85 CYP1A2 (0.53) CYP1A2CYP2D6SCN1ASCN2ASCN3A
Propoxycaine SCHEMBL8683800 0.84 CYP1A2 (0.83) CYP1A2CYP2D6SCN1ASCN2ASCN3A
Propoxycaine SCHEMBL29353209 0.84 SCN1A (1.00) CYP1A2CYP2D6SCN1ASCN2ASCN3A
Propoxycaine SCHEMBL83073 0.84 SCN1A (1.00) CYP1A2CYP2D6SCN1ASCN2ASCN3A
SCHEMBL14975593 0.84 CYP1A2 (0.52) CYP1A2CYP2D6SCN1ASCN2ASCN3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060110743-A1 Drug evolution: drug design at hot spots KONISHI YASUO 2006-05-25 US disclosed
WO-2002095393-A2 DRUG EVOLUTION: DRUG DESIGN AT HOT SPOTS NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2002-11-28 WO disclosed